IGF1 and lung carcinoma: The authors showed that KRAS-mutant NSCLC cells depend upon the IGF signal transduction pathway to provide an initial stimulus to the Ras/Raf/MAP-kinase pathway and concluded that therapeutic inhibition of the IGF signal transduction pathway could be particularly effective in KRAS-mutant lung cancer.